Identification and Validation of a Proliferation-Associated Score Model Predicting Survival in Lung Adenocarcinomas

Table 1

Univariate and multivariate analysis of overall survival in LUAD patients from TCGA database.

	Univariable		Multivariable
	HR (95% CI)	value	HR (95% CI)	value
Age
<60	—	—	—
60-70	0.82 (0.56-1.19)	0.29	0.97 (0.66-1.43)	0.88
>70	1.26 (0.87-1.83)	0.22	1.61 (1.09-2.36)	0.02
Stage
Stage I	—	—	—	—
Stage II	2.32 (1.60-3.36)	<0.001	2.35 (1.61-3.43)	<0.001
Stage III	3.30 (2.24-4.85)	<0.001	2.91 (1.96-4.32)	<0.001
Stage IV	3.61 (2.08-6.26)	<0.001	3.20 (1.82-5.62)	<0.001
Gender
Female	—	—	—	—
Male	1.09 (0.81-1.46)	0.59	0.92 (0.68-1.25)	0.595
Score groups (high vs. low)	2.83 (1.95-4.11)	<0.001	2.86 (1.94-4.22)	<0.001